Profil
Peter Greaney worked as the Director of Business Development and Operations at Celgene Corp.
from 2006 to 2018.
He also worked as the Head of Corporate Development at ADC Therapeutics SA. Prior to his professional experience, he earned an undergraduate degree from the University of East Anglia and a doctorate from the University of Nottingham.
Anciens postes connus de Peter Greaney
| Sociétés | Poste | Fin |
|---|---|---|
| CELGENE | Directeur des opérations | 01/01/2018 |
| ADC THERAPEUTICS SA | Corporate Officer/Principal | - |
Formation de Peter Greaney
| University of East Anglia | Undergraduate Degree |
| The University of Nottingham | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ADC THERAPEUTICS SA | Health Technology |
| Entreprise privées | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |